ISMRM 25th Annual Meeting & Exhibition • 22-27 April 2017 • Honolulu, HI, USA
|Sunrise Educational Session: MRI Assessment in Monitoring Cancer Therapy|
ORGANIZERS: Linda Moy, M.D. & Valeria Panebianco, M.D.
Wednesday, 26 April 2017
Skill Level: Intermediate
Slack Channel: #e_cancer_mol_mrs
Session Number: SW07
Cancer therapy is based on combinations of conventional therapies in addition to targeted therapies and interventional techniques. Conventional methods - biochemical markers and symptoms assessment do not accurately predict treatment response. Multiparametric MRI, provides anatomical and emerging functional biomarkers that can improve the classification of therapy response that contribute to improved decision making.
Clinicians and M.D. & Ph.D. researchers who will benefit from tool and techniques for noninvasive imaging of tumor response to therapy with MpMRI.
Upon completion of this course, participants should be able to:
-Define the role of MRI in the management of patient during oncological treatment;
-Identify the dominant MR technique in the assessment of early efficient response to therapy; and
-Recognize the limitations of current MRI techniques to assess response to targeted therapy.
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for